- Product Reviews
- Manufacturer Info
Microbiome Labs FidoSpore Probiotic for Dogs
Microbiome Labs FidoSpore is the first probiotic supplement clinically shown to support digestive health and reduce leaky gut in dogs. FidoSpore contains a unique blend of Bacillus subtilis HU58, Bacillus licheniformis (SL-307), and Pediococcus acidilactici mixed with irresistible defatted, grass-fed beef liver for flavor and aroma. In fact, a recent study exploring gut dysbiosis in dogs found that FidoSpore dramatically reduced inflammation, diarrhea, and vomiting in as little as 30 days.(1)
- Probiotic for dogs.
- Supports healthy digestion
- Immune support
(1) TEFANU, CL. Evaluation of The Effect of a Probiotic Product With Sporulated Bacilli On Endotoxemia In Dogs With Intestinal Dysbiosis - Pilot Study. University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca. 2019.
1 capsule contains:
Proprietary Probiotic Blend 4 Billion CFU
---Bacillus subtilis, HU58
---Bacillus licheniformis (SL-307)
Defatted Grass-fed Beef liver extract 180mg
Other Ingredients: cellulose, vegetable capsule (cellulose and water).
Contains NO: wheat, gluten, dairy, soy, nuts or chicken.
Dogs: Add 1 capsule to your canine's food once daily. Capsule can be opened and sprinkled onto food or consumed whole.
This product is intended for intermittent or supplemental feeding only. Keep out of the reach of children and animals. In case of overdose, contact a health professional right away.
About Microbiome Labs
The origin story of Microbiome Labs is a classic tale of forging new frontiers, complete with discovery, adversity, and a leap of faith. Neither founder set out on a path to start his own supplement company, but through persistent curiosity Dr. Tom Bayne and Microbiologist Kiran Krishnan stumbled upon an amazing opportunity.
With a rich background in research, Kiran noticed that many supplement companies were lacking sufficient clinical data, which inspired him to design trials that were more affordable and fitting for the supplement industry. He then expanded his skill set into product development and formulation for a number of retail supplement companies. Eventually he was hired to study probiotics and discover what would become the next big probiotic in the industry: Bacillus spores.
Before Kiran discovered the spores, Dr. Tom took a step back from supplement manufacturing and settled into his own chiropractic practice. As his practice began to blossom, he found himself on the forefront of Functional Medicine, uniquely focused on his patients’ gut health. For years, probiotics had proven so ineffective and inconsistent that he eventually quit using them in his practice altogether – that is, until he saw the research that Kiran had uncovered.
With Dr. Tom’s clinical expertise and Kiran’s probiotic research, the serendipitous pair formulated the first all-spore probiotic known as MegaSporeBiotic. After a great deal of clinical validation, the team set out to launch the product in the practitioner market by attending medical conferences.
In 2014, the company exhibited at only 6 conferences and signed on a handful of new accounts. However, as the product sales began to grow, the company chose to reallocate the majority of the profits back into research, with only a minimal amount leftover for marketing. This unorthodox approach is far and away what continues to set Microbiome Labs apart from the rest of the supplement industry.
In doing so, Microbiome Labs hopes to encourage other supplement companies to follow suit, thereby raising the bar of the supplement industry as a whole. In 2018, Microbiome Labs attended over 148 conferences, initiated and/or completed 14 clinical trials, and provided key solutions to thousands of practitioners, changing over 344,000 lives… and counting.
Join us in our mission to Make Vibrant Health Accessible for All.
The Microbiome Labs Team